Who has invested in Mega Genomics?

Meinian OneHealth, Maccura Biotechnology are named among the investors backing Mega Genomics.

Mega Genomics Funding: $20M Raised, IPO (2022)

Mega Genomics funding overview

Mega Genomics is based in Beijing, China. Mega Genomics has raised $20M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is an IPO announced in June 2022. The round record for Mega Genomics runs through 2022; nothing later has been disclosed. Investors on record include Meinian OneHealth, Maccura Biotechnology. 2 distinct backers are named across the disclosed rounds.

Mega Genomics at a glance

Total raised: $20M
Latest round: IPO
Latest round date: June 2022
Headquarters: Beijing, China
Notable investors: Meinian OneHealth, Maccura Biotechnology

Frequently asked about Mega Genomics funding

How much has Mega Genomics raised?: Mega Genomics has raised $20M in total disclosed funding across the rounds on record.
Who has invested in Mega Genomics?: Meinian OneHealth, Maccura Biotechnology are named among the investors backing Mega Genomics.
What was the latest Mega Genomics funding round?: The most recent disclosed round is an IPO, announced in June 2022.
Where is Mega Genomics based?: Mega Genomics is based in Beijing, China.
When did Mega Genomics last raise?: The last disclosed Mega Genomics round closed in June 2022 at IPO.

Mega Genomics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Beijing below to benchmark round size and investor mix.

Mega Genomics Funding: $20M Raised, IPO (2022)

Mega Genomics funding overview

Mega Genomics at a glance

Frequently asked about Mega Genomics funding

Companies related to Mega Genomics (18)

Browse related funding lists (5)